Equity Details
Price & Market Data
Price: $0.858
Daily Change: -$0.01 / 1.17%
Daily Range: $0.834 - $0.912
Market Cap: $44,503,948
Daily Volume: 123,606
Performance Metrics
1 Week: -5.03%
1 Month: 10.16%
3 Months: 2.56%
6 Months: -30.85%
1 Year: 64.43%
YTD: -24.78%
About Talphera, Inc. (TLPH)
Essential market overview for Talphera, Inc. (TLPH). Current price: 0.858, daily change: -$0.01 / 1.17%. Market cap: 44,503,948. All key performance metrics for a full analysis.
Company Details
Employees: 12
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Talphera, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. The company's lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, a nafamostat formulation for direct IV infusion as an investigational product for various indications, such as antiviral, acute respiratory distress syndrome, disseminated intravascular coagulation, and acute pancreatitis, as well as Fedsyra and phenylephrine ready-to-use pre-filled syringe product candidates. The company was formerly known as AcelRx Pharmaceuticals, Inc. and changed its name to Talphera, Inc. in January 2024. The company was incorporated in 2005 and is based in San Mateo, California.